ANTISTREPTOLYSIN - ANVISA Registration 81246980002
Access comprehensive regulatory information for ANTISTREPTOLYSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81246980002 and manufactured by ORTHO CLINICAL DIAGNOSTIC, INC. The registration is held by ORTHO CLINICAL DIAGNÓSTICS DO BRASIL PRODUTOS PARA SAÚDE LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., KOVALENT DO BRASIL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81246980002
25351455152201743
21921393000146
Company Information
Dates and Status
Aug 28, 2017
VIGENTE
09/18/2025 19:00:01
ANTIESTREPTOLISINA
Celer Finecare ASO Teste Quantitativo
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410146
Jul 14, 2025
ANTIESTREPTOLISINA
Família Antiestreptolisina O (ASLO)
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390325
Jun 09, 2025
ANTIESTREPTOLISINA
Família ASO HL
KOVALENT DO BRASIL LTDA
80115310299
Feb 17, 2025
ANTIESTREPTOLISINA
Atellica CH Antiestreptolisina-O_3 (ASO_3)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162467
May 15, 2023
ANTIESTREPTOLISINA
FAMÍLIA ASO
VYTTRA DIAGNOSTICOS S.A.
81692610279
Apr 10, 2023

